Home | Business News | Browse by Publication | S | San Diego Business Journal

Isis licenses cancer drug candidate.

Publication: San Diego Business Journal
Publication Date: 27-SEP-04
Format: Online
Delivery: Immediate Online Access
Full Article Title: Isis licenses cancer drug candidate.(Biotech)(Brief Article)

Article Excerpt
Carlsbad-based biotechnology firm Isis Pharmaceuticals Inc. recently announced it licensed a second-generation cancer drug candidate to its collaborator Eli Lilly and Co., triggering a $750,000 payment.

Isis said Sept. 20 that the big pharmaceutical maker Lilly, based in Indianapolis, plans to test the compound for safety in humans this...

Access Full Article, Compliments of Goliath

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from San Diego Business Journal
Diversa Corp.'s efforts lead to $300,000 milestone payment.(Biotech)(B..., September 27, 2004
Cyntellect Inc. wins $1.5 million grant.(Biotech)(Brief Article), September 27, 2004
Enterprise Partners adds manpower.(Biotech)(Benjamin Myers)(Brief Arti..., September 27, 2004
Publications.(Directory)(Illustration), September 27, 2004
Radio stations.(Directory)(Illustration), September 27, 2004

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.